HCFA (US Health Care Financing Administration) extends clinical trials reimbursement under Medicare
This article was originally published in Clinica
Companies manufacturing new medical devices for the US market may be entitled to greater assistance with development costs. So said the US Health Care Financing Administration, the body that runs the federal health plan for the elderly and disabled, in proposals issued on August 4.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.